๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
NCT06025578Progressive Pulmonary Fibrosis
Bristol-Myers Squibb
Phase 3
1,057
Hefei, Beijing, Lanzhou, Guangzhou, Shenzhen, Shenzhen Shi, Zhengzhou, Shijiazhuang
2023-10-25
Recruiting
Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC
NCT06904014HCC
Lei ZHAO
Phase 2
40
Jinan
2023-10-25
By invitation
T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
NCT06481956HER2-positive Advanced Breast Cancer
Zheng Yabing
Phase 2
40
Hangzhou
2023-10-25
Recruiting
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
NCT06099821Digestive System Cancers
Peking University Cancer Hospital & Institute
Phase 2
39
Beijing
2023-10-25
Recruiting
A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
NCT06190639Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital
Phase 2
31
Hangzhou
2023-10-25
Not yet open
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)
NCT06112041Carcinoma, Solid Tumor
Second Affiliated Hospital of Soochow University
Phase 2
29
Suzhou
2023-10-25
Recruiting
Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
NCT05965024Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Observational
377
Shanghai
2023-10-25
Recruiting
The Correlation Between Ovarian Function and Serum Biomarkers
NCT06096766Premature Ovarian Insufficiency, Diminished Ovarian Reserve, Biomarker, Copper
Shi Yun
Observational
35
Beijing
2023-10-25
Active, closed
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT06052059Ulcerative Colitis
Merck Sharp & Dohme LLC
Phase 3
1,020
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Guangzhou, Huizhou
2023-10-25
Recruiting
Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia
NCT06041659Moyamoya Disease
Beijing Tiantan Hospital
Observational
48
Beijing
2023-10-24
Recruiting
Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients
NCT06176729Diffuse Large B Cell Lymphoma
Yan Zhang, MD
Phase 2
30
Beijing
2023-10-24
Recruiting
Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity
NCT06720766Fatty Liver Disease
The Third People's Hospital of Chengdu
Observational
600
Chengdu
2023-10-24
Active, closed
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
NCT06058416Hepatitis A
Sinovac Biotech Co., Ltd
Phase 4
1,092
Shenyang
2023-10-24
Active, closed
Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery
NCT06062550Scoliosis Correction, Esketamine, Dexmedetomidine, Postoperative Analgesia
Peking University First Hospital
Phase 4
312
Beijing
2023-10-24
Recruiting
Effect of FPCA on Incidence of Emergency Delirium in Children After Surgery
NCT06092671Postoperative Complications, Child, Family, Emergence Delirium
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
444
Wenzhou
2023-10-24
Active, closed
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
NCT05949684Myelodysplastic Syndromes
Bristol-Myers Squibb
Phase 3
402
Hefei, Beijing, Chongqing, Xiamen, Shijiazhuang, Harbin, Zhengzhou, Wuhan
2023-10-24
Active, closed
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.
NCT05984277Metastatic Non-small Cell Lung Cancer
AstraZeneca
Phase 3
895
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2023-10-24
Recruiting
Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies
NCT06145841AIDS, Pneumonia, Sepsis, Neonatal
Guangzhou 8th People's Hospital
Observational
400
Guangzhou
2023-10-23
Active, closed
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06165380Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapies
Li Zhang
Phase 2
43
Wuhan
2023-10-23
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenstrรถm Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
BeOne Medicines
Phase 2
114
Xiamen, Guangzhou, Zhengzhou, Wuhan, Yancheng, Shenyang, Qingdao, Shanghai
2023-10-23
Not yet open
Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)
NCT05988372Locally Advanced Pancreatic Cancer
Sun Yat-sen University
Phase 2
50
Guangzhou
2023-10-23
Recruiting
Xerostomia-optimised IMRT Versus Standard IMRT in NPC
NCT06282497Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy
Zhongshan People's Hospital, Guangdong, China
Not applicable
524
Zhongshan
2023-10-23
Recruiting
Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock
NCT06145828AIDS Pneumonia, Septic Shock
Guangzhou 8th People's Hospital
Observational
60
Guangzhou
2023-10-23
Recruiting
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
NCT06084936Lymphoma
Hoffmann-La Roche
Phase 3
182
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanning, Shanghai
2023-10-22
Recruiting
BGT007H Cells for the Treatment of Refractory Digestive System Tumors
NCT06104215Digestive Tract Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase EARLY_PHASE1
14
Xuzhou
2023-10-22
Active, closed
A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares
NCT06013969Generalized Pustular Psoriasis
LEO Pharma
Phase 4
42
Guangzhou, Shanghai
2023-10-22
Recruiting
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
NCT06104241Gastrointestinal Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase EARLY_PHASE1
14
Xuzhou
2023-10-22
Active, closed
Clinical Study of CEP+Dasatinib + Azacytidine in First-line Treatment of. Angioimmunoblastoma Foresight
NCT07046182Angioimmunoblastic T-cell Lymphoma (AITL)
Zhengzhou University
Phase 4
34
Zhengzhou
2023-10-21
Recruiting
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
NCT06006169Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
186
Shanghai
2023-10-20
Recruiting
The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery
NCT06104774Thoracic Neoplasms
China Medical University Hospital
Not applicable
200
2023-10-20
Recruiting
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
NCT06118762Metastatic Colorectal Cancer
The First Affiliated Hospital of Nanchang University
Phase 4
30
Nanchang
2023-10-20
Recruiting
Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
NCT06140966Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
54
Wuhan
2023-10-20
Not yet open
Study on the Safety and Effectiveness of the SnowyTM PFO Closure System
NCT05360771Patent Foramen Ovale
Hangzhou Dinova EP Technology Co., Ltd
Not applicable
242
Nanjing
2023-10-20
Recruiting
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
NCT06084962Relapse/Refractory Multiple Myeloma
He Huang
Phase 1
40
Hangzhou
2023-10-20
Recruiting
A Study of the Safety and Efficacy of Intelligent Powered Exoskeletons in Postoperative Spinal Rehabilitation
NCT06097000Exoskeleton Device
Xuanwu Hospital, Beijing
Not applicable
80
Beijing
2023-10-20
Recruiting
A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
NCT06049290Relapsed/Refractory Multiple Myeloma
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
342
Wuhu, Beijing, Xiamen, Guangzhou, Shenzhen, Guiyang, Haikou, Luoyang
2023-10-20
Recruiting
Comparison of a Single Versus Double Perclose Technique for TAVR
NCT06173115Severe Aortic Stenosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
876
Bengbu, Fuzhou, Lanzhou, Guangzhou, Zhanjiang, Yulin, Changshacun, Zhengzhou
2023-10-20
Not yet open
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
NCT05993858Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
33
Wuhan
2023-10-20
Recruiting
NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma
NCT06167109Nasopharyngeal Carcinoma by AJCC V8 Stage
Chongqing University Cancer Hospital
Not applicable
60
Chongqing
2023-10-20
Recruiting
A Study of IBI363 in Subjects With Advanced Melanoma
NCT06081920Melanoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
180
Beijing, Fuzhou, Zhengzhou, Changsha, Nanjing, Nanchang, Changchun, Jinan
2023-10-19
Active, closed
A Study of BN104 in the Treatment of Acute Leukemia
NCT06052813ALL, Adult, AML, Adult, Acute Leukaemia, KMT2A Rearrangement
Institut de Recherches Internationales Servier (I.R.I.S.)
Phase 1/2
66
Suzhou
2023-10-19
Recruiting
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
NCT05991908Acute Myeloid Leukemia, Myelodysplastic Syndromes
Shanghai Jiao Tong University School of Medicine
Phase 3
222
Fuzhou, Xiamen, Nanning, Nanjin, Suzhou, Shanghai, Kunming
2023-10-19
Recruiting
Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS
NCT06046313Acute Myeloid Leukemia, Myelodysplastic Syndromes
First Affiliated Hospital of Zhejiang University
Phase 2
120
Hangzhou
2023-10-19
Active, closed
A Single-center, Prospective Study for Mechanism and Risk Factors of Tracheal Tube-related Tongue Injury
NCT05987293Tracheal Tube-related Tongue Injury
China-Japan Friendship Hospital
Observational
94
Beijing
2023-10-19
Recruiting
Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
NCT06389760Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
57
Nanjing
2023-10-18
Recruiting
A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis
NCT06136429Severe Aortic Stenosis
Pan Xiangbin
Not applicable
120
Beijing
2023-10-18
Recruiting
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
NCT06054906Gastric Cancer
Huashan Hospital
Phase 2
50
Shanghai
2023-10-18
Not yet open
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer
NCT06063070Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer, Primary Peritoneal Cancer
Sun Yat-sen University
Phase 2
44
Guangzhou
2023-10-18
Recruiting
An Imaging Study of Polyvascular Disease
NCT06016608Polyvascular Disease
Harbin Medical University
Observational
1,100
Harbin
2023-10-18
Recruiting
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
NCT05944224Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1/2
63
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Yongzhou, Shenzhen, Xiโ€™an
2023-10-17
Recruiting
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
NCT06111274Advanced Pancreatic Cancer
Abbisko Therapeutics Co, Ltd
Phase 2
82
Shanghai, Chengdu, Haโ€™erbin, Wuhan
2023-10-17
Recruiting
Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability
NCT05920174Tetraplegia
Neuracle Medical Technology(Shanghai) Co.,Ltd.
Not applicable
9
Beijing, Shanghai
2023-10-17
Recruiting
Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease
NCT06588231Coronary Heart Disease
The First Affiliated Hospital with Nanjing Medical University
Not applicable
200
Nanjing
2023-10-17
By invitation
Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases
NCT06690684Angiocardiography, Heart Failure, Ischemic Heart Disease, Acute Myocardial Infarction (AMI)
Ya-Wei Xu
Observational
300
Shanghai
2023-10-17
Recruiting
De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC
NCT06572514Locally Advanced Head and Neck Squamous Cell Carcinoma
Ruijin Hospital
Phase 1/2
20
Shanghai
2023-10-17
Recruiting
A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2)
NCT05989542Non-small Cell Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company
Phase 3
136
Guangzhou
2023-10-16
Recruiting
Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
NCT06084897Esophageal Neoplasm Metastatic, Esophageal Cancer Stage IVb
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
120
Beijing
2023-10-16
Recruiting
Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
NCT06112067Deep Brain Stimulation
Shanghai Mental Health Center
Not applicable
18
Shanghai
2023-10-16
Active, closed
A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors
NCT05951608Advanced Solid Tumors
Akeso
Phase 1/2
216
Harbin
2023-10-16
Recruiting
Graves' Disease Remission Study: MycoMeth Combo
NCT06068179Graves' Disease
The First Affiliated Hospital of Xiamen University
Phase 2/3
205
Xiamen
2023-10-16
Active, closed
PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes
NCT06091267Myelodysplastic Syndromes
Otsuka Beijing Research Institute
Phase 1/2
72
Hangzhou
2023-10-16
Not yet open
The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal Cancer
NCT06092242Colorectal Cancer
The Second Affiliated Hospital of Shandong First Medical University
Phase 2
50
Taiโ€™an
2023-10-15
Recruiting
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
NCT05848310Biliary Atresia, Prognosis
Children's Hospital of Fudan University
Observational
200
Shanghai
2023-10-15
Active, closed
STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial
NCT06084000Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis
China National Center for Cardiovascular Diseases
Not applicable
2,700
Beijing
2023-10-15
Recruiting
Cohort of Twin Pregnancy and the Offspring
NCT05727085Twin Pregnancy
Fudan University
Observational
1,000
Shanghai
2023-10-15
Not yet open
Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer
NCT06079242Colorectal Neoplasms
GrandPharma (China) Co., Ltd.
Observational
200
Hangzhou
2023-10-15
Recruiting
DAREONโ„ข-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT05882058Small Cell Lung Carcinoma, Neuroendocrine Neoplasms, Extra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim
Phase 2
204
Chengdu, Hangzhou, Jinan, Nanchang, Shanghai
2023-10-13
By invitation
A Prospective, Multicenter, Post-marketing Clinical Follow-up Research to Evaluate the Long-term Safety of Ellansรฉ-S Dermal Filler Made of PCL Microspheres for the Correction of Moderate-to-severe Nasolabial Folds
NCT06243315Moderate-to-severe Nasolabial Folds (3-4 Level of WSRS Scores) on Both Sides of the Face
AQTIS Medical B.V.
Observational
374
Guangzhou
2023-10-12
Recruiting
A Study to Compare the Efficacy and Safety of LY01015 and Opdivoยฎ Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT06022861Esophageal Squamous Cell Carcinoma
Shandong Boan Biotechnology Co., Ltd
Phase 3
510
Guangzhou
2023-10-12
Active, closed
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
NCT06095115Plaque Psoriasis
Janssen Research & Development, LLC
Phase 3
684
Beijing, Bengbu, Chengde, Chengdu, Jiaxing, Jinan, Nanchang, Nanyang
2023-10-12
Recruiting
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
NCT06021197Schizophrenia
China Medical University Hospital
Phase 2
90
2023-10-12
Recruiting
A Clinical Study on the Efficacy of Cognitive Distraction Focus Relaxation Therapy Based on MR
NCT06290011Pain
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
132
Shanghai
2023-10-11
Recruiting
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
NCT05681650HER2 Positive Advanced Solid Tumors
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2023-10-11
Recruiting
Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
NCT06052098Stage IA Lung Cancer
Hangzhou Broncus Medical Co., Ltd.
Not applicable
110
Shanghai
2023-10-11
Recruiting
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
NCT06451172Bacterial Keratitis, Antibiotic-resistant Bacteria, Infections, Bacterial, Corneal Diseases
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1
20
Shanghai
2023-10-11
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
NCT06012240Alopecia Areata
AbbVie
Phase 3
1,500
Beijing, Chongqing, Guangzhou, Shenzhen, Wuhan, Nanchang, Changchun, Xi'an
2023-10-11
Recruiting
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
NCT07247227NSCLC
Peking Union Medical College
Not applicable
150
Beijing
2023-10-10
Recruiting
A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies
NCT06038058Advanced Malignancies
BioRay Pharmaceutical Co., Ltd.
Phase 1
164
Guangzhou
2023-10-10
Active, closed
Acute Health Effects of Low Temperature Exposure
NCT06076629Cardiovascular System, Respiratory System, Cognitive Function
Fudan University
Not applicable
50
Shanghai
2023-10-10
By invitation
Platelet Rich Plasma in the Prevention of Adhesion Reformation
NCT06608407Intrauterine Adhesion, Asherman Syndrome
Fu Xing Hospital, Capital Medical University
Not applicable
46
Beijing
2023-10-10
Recruiting
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
NCT06082037Lung Transplant Rejection
Sanofi
Phase 3
180
Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Hefei, Shanghai, Wuxi
2023-10-10
Recruiting
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
NCT05771402Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNฮฑ
The Second Affiliated Hospital of Chongqing Medical University
Phase 2
120
Chongqing
2023-10-10
Recruiting
A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency
NCT06067529Premature Ovarian Insufficiency
Women's Hospital School Of Medicine Zhejiang University
Observational
1,080
Hangzhou
2023-10-10
Recruiting
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
NCT05769816Chronic Hepatitis b, Anti-PD-1 Antibody
The Second Affiliated Hospital of Chongqing Medical University
Phase 2
120
Chongqing
2023-10-10
Recruiting
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors
NCT06152757Gastrointestinal Tumors
BioSyngen Pte Ltd
Phase EARLY_PHASE1
14
Zhengzhou
2023-10-09
Active, closed
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
NCT06008756Arteriosclerosis, Hypercholesterolaemia
Merck Sharp & Dohme LLC
Phase 3
14,550
Hefei, Beijing, Chongqing, Foshan, Guangzhou, Huizhou, Jiangmen, Shenzhen
2023-10-09
Recruiting
Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions
NCT06021080Renal Injury, Regional Citrate Anticoagulation, Continuous Renal Replacement Therapy
Fujian Provincial Hospital
Observational
30
Fuzhou
2023-10-09
Recruiting
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
NCT06055738Locally Advanced Cervical Cancer
Tang-Du Hospital
Phase 2
20
Xi'an
2023-10-09
Recruiting
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
NCT06092957Nasopharyngeal Carcinoma, De-escalation Therapy
Sun Yat-sen University
Phase 3
504
Guangzhou
2023-10-09
Recruiting
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
NCT06560827HCC
CARsgen Therapeutics Co., Ltd.
Phase 1
30
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guanzhou, Hangzhou, Shanghai
2023-10-08
Recruiting
Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis
NCT06307080Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
12
Shanghai
2023-10-08
Recruiting
Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease
NCT06107400Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Phase EARLY_PHASE1
5
Nanning
2023-10-08
Active, closed
Predicting Illness Trajectories In Fully Remitted Major Depression Using Concurrent TBS/fNIRS
NCT05579015Major Depression in Remission, Healthy
The Hong Kong Polytechnic University
Not applicable
170
Hong Kong
2023-10-08
Active, closed
Preoperative Evaluation of 3D Reconstruction Tool for Nipple-sparing Mastectomy
NCT06071234Breast Cancer
Guangdong Provincial People's Hospital
Not applicable
126
Guangzhou
2023-10-08
Recruiting
Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC
NCT06061146Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
136
Tianjin
2023-10-05
Active, closed
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
NCT05952557Breast Cancer, Early Breast Cancer
AstraZeneca
Phase 3
5,511
Baoding, Beijing, Bengbu, Binzhou, Cangzhou, Changchun, Changsha, Chengdu
2023-10-05
Not yet open
Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
NCT05540275Recurrent Glioblastoma
Henan Provincial People's Hospital
Phase 2
30
Zhengzhou
2023-10-05
Recruiting
NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
NCT05977023Bipolar I Disorder
China Medical University Hospital
Phase 2
90
2023-10-04
Recruiting
ML Models Predicting Cycloplegic Refractive Error Based on Non-Cycloplegic Parameters in Myopic Adults
NCT07690813Refractive Errors, Cycloplegic Refraction, Accommodation
Second Affiliated Hospital of Nanchang University
Observational
2,500
Jiangxi
2023-10-03
By invitation
A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
NCT06044337Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
Biogen
Phase 3
306
Beijing, Shenzhen, Dongguan, Guangzhou, Changsha, Nanjing, Shanghai, Kunming
2023-10-03
Rows per page Showing 14501–14600 of 19052
Previous 144 145 146 147 148 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china?page=146

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.